Quoin Pharmaceuticals Ltd DRC (QNRX) — Financial Flexibility Index
Quoin Pharmaceuticals Ltd DRC (QNRX) has a Financial Flexibility Index of -0.70x as of March 2026. Free cash flow of $-4.87 Million (operating CF $-4.87 Million minus capex $0.00) represents -1% of total liabilities ($6.92 Million). Check QNRX asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Quoin Pharmaceuticals Ltd DRC Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Quoin Pharmaceuticals Ltd DRC across 11 annual periods. See QNRX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Quoin Pharmaceuticals Ltd DRC (2015–2025)
Year-by-year free cash flow to debt coverage for Quoin Pharmaceuticals Ltd DRC. For the full company profile including market capitalisation, see QNRX market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.86x | $-13.54 Million | $-13.54 Million | $7.27 Million | ▼ -54.2% |
| 2024 | -1.21x | $-7.86 Million | $-7.86 Million | $6.50 Million | ▲ +0.1% |
| 2023 | -1.21x | $-7.86 Million | $-7.86 Million | $6.51 Million | ▼ -3.6% |
| 2022 | -1.17x | $-8.23 Million | $-8.48 Million | $7.05 Million | ▼ -99.3% |
| 2021 | -0.59x | $-5.10 Million | $-5.72 Million | $8.70 Million | ▼ -285.3% |
| 2020 | -0.15x | $-1.21 Million | $-1.34 Million | $7.99 Million | ▲ +95.0% |
| 2019 | -3.02x | $-5.67 Million | $-5.71 Million | $1.88 Million | ▲ +15.0% |
| 2018 | -3.56x | $-6.39 Million | $-6.57 Million | $1.80 Million | ▼ -140.7% |
| 2017 | -1.48x | $-4.90 Million | $-4.98 Million | $3.32 Million | ▲ +39.4% |
| 2016 | -2.44x | $-3.44 Million | $-3.77 Million | $1.41 Million | ▲ +5.6% |
| 2015 | -2.58x | $-1.90 Million | $-1.98 Million | $735.02K | — |